<?xml version="1.0" encoding="UTF-8"?>
<p>In addition to antiviral property, baricitinib has been suggested as an approach for a cytokine storm syndrome, which features hypercytokinemia and multi-organ failure. Elevated ferritin and IL-6 in COVID-19 cases were predictive of a high mortality rate according to a China retrospective study.
 <sup>
  <xref rid="bibr17-1759720X20947296" ref-type="bibr">17</xref>
 </sup> Baricitinib inhibits cytokines including IL-2, IL-6, IL-10, interferon gamma (IFN-Î³), and granulocyte-colony-stimulating factor (G-CSF)
 <sup>
  <xref rid="bibr13-1759720X20947296" ref-type="bibr">13</xref>,
  <xref rid="bibr18-1759720X20947296" ref-type="bibr">18</xref>
 </sup> and may bring the benefit of immune reconstruction which could be used in rapidly progressive diseases.
</p>
